Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.1295
-0.0030 (-2.26%)
May 22, 2026, 9:59 AM EST
Nymox Pharmaceutical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
13.52M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 5.00K | -111.00K | -95.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionNymox Pharmaceutical News
- 7 weeks ago - NYMOX Provides Recent Updates - Accesswire
- 1 year ago - Nymox Announces Dismissal of Delaware Action Against Ascella - GlobeNewsWire
- 1 year ago - Nymox resumes trading with listing on OTCQB - TheFly
- 1 year ago - NYMOX Announces Trading Resumed and New Listing on OTCQB Market - GlobeNewsWire
- 1 year ago - Nymox Announces Filing of Annual Report - GlobeNewsWire
- 2 years ago - Nymox Annual Report - GlobeNewsWire
- 2 years ago - Nymox Required to Resubmit Application to DKMA - GlobeNewsWire
- 2 years ago - Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages - GlobeNewsWire